Anna Bagnato

Anna Bagnato was born in 1960, in Italy. She obtained her Biological Science Degree in 1984 at the Sapienza University of Rome (Italy) and later in 1989, her specialization in General Pathology from the same University. After a period of two years as Visiting Scientist at the National Institutes of Health (NIH), Endocrinology and Reproduction Research Branch, Bethesda, MD, USA, headed by Dr. K. Catt, she moved up through the ranks at the Regina Elena Cancer Institute of Rome, from Group Leader to Head of the Unit of Preclinical Models and New Therapeutic Agents, a position she held from 2016. She was a member of the Scientific Advisory Board of AIRC from 2015. She has published over 120 peer-reviewed papers (H-index 46), was an invited speaker to several international scientific meetings and was awarded with different honours. She has served as advisor, chairman for many prestigious societies, and funding agencies worldwide. Dr. Bagnato is a member of the editorial board of several international scientific journals and is a member of numerous professional associations including the American Association for Cancer Research and the European Association for Cancer Research. Dr. Bagnato manages a large team of scientists and related laboratory technicians. Her work is mainly focused on the inter-cellular communications in the tumor ecosystem, defining the role of G-protein coupled receptors, and in particular of endothelin-1 receptors, in ovarian cancer progression and response to therapy, with the ultimate goal to devise novel therapeutic strategies.